About the Authors

Aida Attar

Affiliations Department of Neurology, University of California Los Angeles, Los Angeles, California, United States of America, Brain Research Institute, University of California Los Angeles, Los Angeles, California, United States of America

Tingyu Liu

Affiliation Department of Neurology, University of California Los Angeles, Los Angeles, California, United States of America

Wai-Ting Coco Chan

Affiliation Department of Neurology, University of California Los Angeles, Los Angeles, California, United States of America

Jane Hayes

Affiliation Department of Neurology, University of California Los Angeles, Los Angeles, California, United States of America

Mona Nejad

Affiliation Department of Neurology, University of California Los Angeles, Los Angeles, California, United States of America

KaiChyuan Lei

Affiliation Department of Neurology, University of California Los Angeles, Los Angeles, California, United States of America

Gal Bitan

gbitan@mednet.ucla.edu

Affiliations Department of Neurology, University of California Los Angeles, Los Angeles, California, United States of America, Brain Research Institute, University of California Los Angeles, Los Angeles, California, United States of America, Molecular Biology Institute, University of California Los Angeles, Los Angeles, California, United States of America

Competing Interests

Gal Bitan is a founder and a shareholder of Clear Therapeutics Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: AA GB. Performed the experiments: AA TL WTCC JH MN KCL. Analyzed the data: AA TL WTCC JH MN KCL GB. Wrote the paper: AA GB.